Mitch Sanders, PhD is CEO of ProDevLabs LLC, a premier wound care R&D and Preclinical CRO. Mitch has 40 years of experience in diagnostics, preclinical animal models, and clinical product development of novel drugs, biologics, and medical devices. He has raised tens of millions of dollars from strategic partners such as Pfizer, Astra Zeneca, and Johnson & Johnson. He has 65+ peer reviewed papers and granted world-wide patents (Google Scholar citations, https://bit.ly/3otr4a3). Dr. Sanders has been a Founder, CEO, and/or CSO of companies including but not limited to Alira Health, ECI Biotech, Lobstagen, and WoundForce Inc. He holds a B.S. in Biology from Boston University, and an M.S. and Ph.D. from Worcester Polytechnic Institute in Molecular Biology and Biomedical Sciences and has completed two post-doctoral appointments at MIT.